When your patients are referred to Fox Chase Cancer Center’s Urologic Oncology department, chances are that the first person they will talk with will be Tina Larason. She is the office’s lynchpin, a 15-year Fox Chase veteran who is dedicated to making patie...
Read More
Two Fox Chase Cancer Center urologic oncologists participated in presentations at the spring 2018 annual meeting of the American Urological Association (AUA) and the Society for Urologic Oncology (SUO). Rosalia Viterbo, MD, FACS, brought her extensive ex...
Read More
Fox Chase Cancer Center’s Robert G. Uzzo, MD, FACS, received the 2018 SUO Medal from the Society of Urologic Oncology (SUO) for his significant contributions to the field of urologic oncology. This prestigious award is presented to one member of SUO annuall...
Read More
While the standard of care for muscle invasive bladder cancer is to remove the entire bladder, in some 30 percent of patients, these organs do not harbor residual cancer, especially after chemotherapy treatment. Today, there is no reliable way to identif...
Read More
Fox Chase physicians are on the cutting edge when it comes to management of adrenal mass. At Fox Chase Cancer Center, our multidisciplinary medical team works closely to assess the patient’s adrenal mass and help them understand their options so that the...
Read More
Novel surgical and radiation techniques are making it easier for some patients with prostate cancer to prolong their lives following treatment. By employing the most modern clinical tools, Fox Chase Cancer Center offers the latest in imaging and prostate bi...
Read More
